These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 11565394)

  • 1. Taking issue with breast cancer statistics.
    Aickin M
    Altern Ther Health Med; 2001; 7(5):20. PubMed ID: 11565394
    [No Abstract]   [Full Text] [Related]  

  • 2. Breast cancer trends.
    Weiss NS
    Epidemiology; 2007 Mar; 18(2):284; author reply 284-5. PubMed ID: 17301717
    [No Abstract]   [Full Text] [Related]  

  • 3. Breast cancer survivors in the United States: geographic variability and time trends, 2005-2015.
    De Angelis R; Tavilla A; Verdecchia A; Scoppa S; Hachey M; Feuer EJ; Mariotto AB
    Cancer; 2009 May; 115(9):1954-66. PubMed ID: 19248047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical classification of extent of disease in cancer of the breast.
    Cutler SJ; Myers MH
    J Natl Cancer Inst; 1967 Aug; 39(2):193-207. PubMed ID: 18623939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer in nuns.
    Roisman I; Bitterman A; Mohamad H; Lefel O; Peleg T; Kovacs Z; Cohen O; Lifshitz I; Rephaely G; Durst AL
    Breast J; 2004; 10(5):465. PubMed ID: 15327508
    [No Abstract]   [Full Text] [Related]  

  • 6. Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome.
    Anderson WF; Jatoi I; Devesa SS
    Breast Cancer Res Treat; 2005 Mar; 90(2):127-37. PubMed ID: 15803359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer presents at an earlier age in Mexican American women.
    Boyle T; McPadden E
    Breast J; 2004; 10(5):462-4. PubMed ID: 15327507
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of statistics to assess the global burden of breast cancer.
    Parkin DM; Fernández LM
    Breast J; 2006; 12 Suppl 1():S70-80. PubMed ID: 16430400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stat bite: Incidence of in situ and invasive breast cancer by age, 1975-2001.
    J Natl Cancer Inst; 2004 Oct; 96(20):1496. PubMed ID: 15494597
    [No Abstract]   [Full Text] [Related]  

  • 10. IMS reaction to recent breast cancer data.
    Pines A; Sturdee DW; Birkhäuser M;
    Climacteric; 2007 Feb; 10(1):9-10. PubMed ID: 17364599
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk factors for breast cancer in older women: the relative contribution of bone mineral density and other established risk factors.
    Cauley JA; Song J; Dowsett SA; Mershon JL; Cummings SR
    Breast Cancer Res Treat; 2007 Apr; 102(2):181-8. PubMed ID: 17028986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone therapy and the rise and perhaps fall of US breast cancer incidence rates: critical reflections.
    Krieger N
    Int J Epidemiol; 2008 Jun; 37(3):627-37. PubMed ID: 18375445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decline in breast cancer incidence--United States, 1999-2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Jun; 56(22):549-53. PubMed ID: 17557070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer in 2007: incidence, risk assessment, and risk reduction strategies.
    Lester J
    Clin J Oncol Nurs; 2007 Oct; 11(5):619-22. PubMed ID: 17962169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial ovarian cancer and low malignant potential (LMP) tumors associated with a lower incidence of second primary breast cancer.
    Hunter MI; Ziogas A; Flores F; Brewster WR
    Am J Clin Oncol; 2007 Feb; 30(1):1-7. PubMed ID: 17278887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond the Gail model: lobular involution may help refine breast cancer risk assessment.
    Rowan K
    J Natl Cancer Inst; 2009 Feb; 101(3):134-5. PubMed ID: 19176450
    [No Abstract]   [Full Text] [Related]  

  • 17. Increasing breast cancer incidence in China: the numbers add up.
    Ziegler RG; Anderson WF; Gail MH
    J Natl Cancer Inst; 2008 Oct; 100(19):1339-41. PubMed ID: 18812546
    [No Abstract]   [Full Text] [Related]  

  • 18. Commentary: Hormone therapy and breast cancer incidence: did epidemiologists miss an effect on national trends?
    Paul C
    Int J Epidemiol; 2008 Jun; 37(3):638-40. PubMed ID: 18375444
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction between genetic variations in DNA repair genes and plasma folate on breast cancer risk.
    Han J; Hankinson SE; Zhang SM; De Vivo I; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):520-4. PubMed ID: 15066914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin use and breast cancer: prospective results from the Women's Health Initiative.
    Cauley JA; McTiernan A; Rodabough RJ; LaCroix A; Bauer DC; Margolis KL; Paskett ED; Vitolins MZ; Furberg CD; Chlebowski RT;
    J Natl Cancer Inst; 2006 May; 98(10):700-7. PubMed ID: 16705124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.